Current challenges in the diagnosis and management of acute coronary syndromes in women

Abstract

Cardiovascular disease remains the leading cause of death among women nowadays. However, there is a persistent lack of awareness of the impact of different risk factors on women's cardiovascular health, in specific pregnancy-related complications, hormonal changes, and psychological aspects. Moreover, there is still not enough awareness of the importance of coronary artery disease (CAD) in women, which leads to a delay in the diagnosis and prompt treatment, particularly during emergent coronary scenarios. Although guidelines suggest the same treatment for women and men who present with acute coronary syndrome (ACS), women are still undertreated. Contemporary data show an improvement over time in the management of ACS in women, however, women are still less likely than men to receive revascularization and pharmacological treatments. Women have higher rates of complications and mortality, in particular the young population, in which all outcomes are still worse in women compared to men. In this review, we aim to emphasize the importance of women's risk factors, women-specific pathophysiology, and clinical presentation in the setting of ACS. This is a review of current challenges in the diagnosis and treatment of women with ACS.

Women in leading positions among authors in cardiology papers: Is the gender gap closing?

“…Cardiovascular disease remains the leading cause of mortality worldwide for both men and women [1]. Gender differences in risk factors, clinical manifestations, and therapy are the subject of extensive research [2,3].…”

Advanced Lung Cancer Inflammation Index for Predicting Prognostic Risk for Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention

“…1 Although great progress has been made in the diagnosis and treatment of ACSs, such as the development of percutaneous coronary intervention and dual antiplatelet therapy and the high prevalence of coronary computed tomographic angiography, ACS remains the leading cause of death worldwide. [2][3][4][5] Accurate assessment of prognostic risk and standard follow-up are widely recognized to be important approaches to improving patient survival. 6 In recent years, research attention has focused on different kinds of inflammatory indices, as a convenient and noninvasive measure for diagnosing and assessing prognostic risks.…”